Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 423 resultados

MiniMI: Generating a 3D Micro necroptosis induced Myocardial Infarction model ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Cardiovascular disease remains one of the leading causes of death worldwide, with more than 4 out of 5 of these due to heart attacks. Follow...
2025-05-01 - 2027-04-30 | Financiado

SPARK: Spatial Metabolic Regulation in Kidney Repair ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: ERC-2023-ADG Chronic kidney disease (CKD) is a global health concern, and the limited treatment options for end-stage kidney disease have remained unchan...
2025-01-01 - 2029-12-31 | Financiado

ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE ACADEMISCH ZIEKENHUIS LEIDEN participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado

SYNTHIA: Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applica... SYNTHIA is an ambitious collaboration between public and private institutions to facilitate the responsible use of Synthetic Data (SD) in he...
2024-08-09 - 2029-08-31 | Financiado

ReproTox: Developing a human-based stem cell model for reproductive toxicity ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: ERC-2024-POC Environmental factors and chemicals are thought to be one cause of declining male fertility. Reproductive toxicity is becoming a major publ...
2024-08-01 - 2026-01-31 | Financiado

SPARK: Spatial Metabolic Regulation in Kidney Repair ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: ERC-2023-ADG Chronic kidney disease (CKD) is a global health concern, and the limited treatment options for end-stage kidney disease have remained unchan...
2024-07-19 - 2029-12-31 | Financiado

ReproTox: Developing a human based stem cell model for reproductive toxicity ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: ERC-2024-POC Environmental factors and chemicals are thought to be one cause of declining male fertility. Reproductive toxicity is becoming a major publ...
2024-07-10 - 2026-01-31 | Financiado

IMPLANTEU: Innovative approaches to implantation research in health and disease ACADEMISCH ZIEKENHUIS LEIDEN participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Implantation of the embryo in a receptive uterus is critical for mammalian reproduction, yet remains poorly understood. This challenge is pa...
2024-07-09 - 2028-09-30 | Financiado

EFFECT: A European Training Program to Foster the Full Therapeutic Potential of Antisense Technology across... "The EFFecT Doctoral Training (DN) Network responds to the evolving landscape of RNA-based therapeutics and in particular antisense oligonuc...
2024-07-05 - 2028-12-31 | Financiado

Adaptmet: Deconstructing adaptive evolution of metastasis Adaptmet aims to develop an advanced training program encompassing the multifaceted aspects of metastasis adaptation mechanisms, intending t...
2024-07-05 - 2029-02-28 | Financiado

CAARE: Characterization and Recovery of Bionanoparticles for Vaccine Delivery and Gene Therapy The Doctoral Network CAARE - Characterization and Recovery of Bionanoparticles for Vaccine Delivery and Gene Therapy focuses on a rapidly em...
2024-06-25 - 2028-09-30 | Financiado

CartoHostBug: Functional cartography of intestinal host microbiome interactions ACADEMISCH ZIEKENHUIS LEIDEN participó en un HORIZON EUROPE: ERC-2023-SyG Microbiome-host crosstalk is crucial for gut homeostasis and its dysregulation is a hallmark of diseases such as colorectal cancer (CRC) and...
2024-06-19 - 2030-06-30 | Financiado

Bugs4Urate: Bugs4Urate Precision Nutrition Strategies for Investigating Probiotic Diet Glycan and Microbiom... ACADEMISCH ZIEKENHUIS LEIDEN participó en un HORIZON EUROPE: HORIZON-EIC-2023-PATHFINDERCHALLENGES-01 Gout is a prevalent lifestyle related NCD on the rise in Europe causing low quality of life, yet with inefficient means for treatment. An ef...
2024-06-04 - 2027-08-31 | Financiado

GLUCOTYPES: Glucose variability patterns for precision nutrition in diabetes ACADEMISCH ZIEKENHUIS LEIDEN participó en un HORIZON EUROPE: HORIZON-EIC-2023-PATHFINDERCHALLENGES-01 Type 2 diabetes (T2D) has emerged as a global epidemic, impacting 1 in 10 people worldwide and causing over 114,000 deaths annually in Europ...
2024-06-03 - 2028-09-30 | Financiado

SPACETIME: SPatial Analysis of Cancer Evolution in the Tumour Immune MicroEnvironment ACADEMISCH ZIEKENHUIS LEIDEN participó en un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 The introduction of immune checkpoint therapy for Non-Small Cell Lung Cancer (NSCLC) has improved clinical outcomes. However, due to primary...
2024-06-03 - 2029-07-31 | Financiado

HemaFAIR: Fostering F.A.I.R. Data and Standards in Rare Hematological Diseases ACADEMISCH ZIEKENHUIS LEIDEN participó en un HORIZON EUROPE: HORIZON-WIDERA-2023-ACCESS-02 Research on rare diseases (RDs) is scarce and fragmented in the EU, leading to delayed diagnoses, limited availability of medicinal products...
2024-05-21 - 2027-06-30 | Financiado

Breaking ANCA: Mucosal Breaks of Bacteria Trigger Pathogenic B-cell Responses in ANCA-associated Vasculitis ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 ANCA-associated vasculitis (AAV) is a rare and severe autoimmune disease, characterized by inflammation of the small blood vessels. ANCAs, a...
2024-05-01 - 2027-04-30 | Financiado

BEAT B-cell Lymphoma: BEAT B-cell Lymphoma: Biomarkers of Effective CART19 Assessed in the Tissue Microenvironment ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 "Project Title: BEAT B-cell Lymphoma: Biomarkers of Effective CART19 Assessed in Tissue microenvironmentB-cell lymphomas, encompassing Folli...
2024-05-01 - 2027-04-30 | Financiado

Leiden University Medical Center